Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 29/Signature 1

From BugSigDB
Needs review

Curated date: 2024/11/11

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 12: Figure S12

Description: Differentially abundant taxa between the VANM group and RZ treatment group.

Abundance in Group 1: increased abundance in RZ (R-Rifampin, Z-Pyrazinamide)

NCBI Quality ControlLinks
Eubacterium
Erysipelotrichaceae
Thomasclavelia
Anaeroplasma
Anaerostipes
Blautia
Akkermansia
Alistipes
Tannerella
Bacteroides

Revision editor(s): KateRasheed